Earnings Feed
Start Free
Home/Filings/3/0001144204-18-056564
3//SEC Filing

Wealth Strategy Holding Ltd 3

Accession 0001144204-18-056564

CIK 0000895051other
View on SEC.govCompany Profile

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 7:24 PM ET

Size

8.0 KB

Accession

0001144204-18-056564

Insider Transaction Report

Form 3
Period: 2018-09-24
CASI Pharmaceuticals, Inc.CASI
Wealth Strategy Holding Ltd
10% Owner
Holdings

  • Warrant

    Exercise: $1.69From: 2017-01-23Exp: 2020-01-23→ Common Stock (493,827 underlying)

  • Warrant

    Exercise: $3.75From: 2018-04-17Exp: 2020-04-17→ Common Stock (666,666 underlying)

  • Warrant

    Exercise: $3.69From: 2018-09-17Exp: 2023-03-21→ Common Stock (370,370 underlying)

  • Warrant

    Exercise: $7.19From: 2019-03-23Exp: 2021-09-24→ Common Stock (559,701 underlying)

  • Common Stock

    8,594,061

Documents

1 file

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

→
Entity typeother
IncorporatedHong Kong

Related Parties

1
  • filerCIK 0001723544

Filing Metadata

Form type
3
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 7:24 PM ET
Size
8.0 KB
View on SEC.gov